Sign In
Buy ASPN
$4.63
+0.120 (+2.66%)
At Close: Jul 31, 2026
Aspen Aerogels: Still Many Questions After A Big Setback
12:21pm, Sunday, 10'th Aug 2025
Aspen Aerogels has stabilized after a dramatic boom-bust cycle that in itself was driven by EV market volatility and overexpansion. Revenue and EBITDA guidance suggest modest improvement, but near-ter
Aspen Aerogels (ASPN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Friday, 08'th Aug 2025
The headline numbers for Aspen Aerogels (ASPN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street es
Aspen Aerogels, Inc. (ASPN) Q2 2025 Earnings Call Transcript
01:49am, Friday, 08'th Aug 2025
Aspen Aerogels, Inc. (NYSE:ASPN ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Donald R. Young - President, CEO & Director Neal Baranosky - Senior Director of Corpor
Aspen Aerogels (ASPN) Reports Q2 Loss, Tops Revenue Estimates
08:40am, Thursday, 07'th Aug 2025
Aspen Aerogels (ASPN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.21 per share a year ago.
Aspen Aerogels, Inc. Reports Second Quarter 2025 Financial Results and Recent Business Highlights
06:30am, Thursday, 07'th Aug 2025
$78 million in quarterly revenue resulted in 32% gross margins and ~2X Adjusted EBITDA improvement QoQ CFO transition to internal successor during Q3 ensures continuation of strategic direction and ex
Aspen Aerogels to Participate in August Investor Conferences
04:30pm, Thursday, 31'st Jul 2025
NORTHBOROUGH, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announce
Aspen Aerogels: Still Cheap Despite +32% Over The Last Month
08:27am, Tuesday, 29'th Jul 2025
Aspen Aerogels' PyroThin technology is driving growth, with strong OEM contracts and a massive addressable market in EV thermal barriers. Despite recent revenue and margin softness, cost-cutting and c
Patient insights informed the development of pilavapadin, Lexicon's investigational, novel, non-opioid treatment for people suffering from DPNP Patient insights informed the development of pilavapadin
Aspen Aerogels, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call
08:00am, Thursday, 17'th Jul 2025
NORTHBOROUGH, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced that Don Young, President & Chief Executive Officer, and Ricardo
Aspen Aerogels, Inc. to Participate in the B. Riley Securities 25th Annual Investor Conference
07:30am, Wednesday, 14'th May 2025
NORTHBOROUGH, Mass. , May 14, 2025 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced
Aspen Aerogels (ASPN) Reports Q1 Earnings: What Key Metrics Have to Say
10:30am, Friday, 09'th May 2025
The headline numbers for Aspen Aerogels (ASPN) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street e
Aspen Aerogels: The Shock Continues
06:54am, Friday, 09'th May 2025
Aspen Aerogels shifted focus from industrial insulation to EVs in recent years, driving initial growth, but its fortunes have reversed due to slow EV adoption. Despite impressive revenue growth in 202
Aspen Aerogels, Inc. (ASPN) Q1 2025 Earnings Call Transcript
04:13pm, Thursday, 08'th May 2025
Aspen Aerogels, Inc. (NYSE:ASPN ) Q1 2025 Results Conference Call May 8, 2025 8:30 AM ET Company Participants Neal Baranosky - Senior Director of Corporate of Strategy & Finance Don Young - President
Aspen Aerogels (ASPN) Reports Q1 Loss, Lags Revenue Estimates
08:55am, Thursday, 08'th May 2025
Aspen Aerogels (ASPN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $0.01 per share a year ago.
Aspen Aerogels, Inc. Reports First Quarter 2025 Financial Results and Recent Business Highlights
06:30am, Thursday, 08'th May 2025
Delivered revenues of $78.7 million and operating cash flow of $5.6 million New PyroThin award with leading American OEM for next-gen prismatic LFP vehicle platform NORTHBOROUGH, Mass. , May 8, 2025 /
